-
-
-
-
discord
-
-
messenger
-
telegram
-
Aidoc Secures $150M funding to Expand AI-Driven Clinical Intelligence Platform
4 days ago
31 views
Clinical AI startup Aidoc has raised $150 million in a Series E funding round, marking a significant push to scale its healthcare intelligence platform and expand the use of artificial intelligence in clinical decision-making.
The round was led by Growth Equity at Goldman Sachs Alternatives, with participation from General Catalyst, SoftBank Investment Advisors, and NVentures, the venture arm of NVIDIA. The latest investment brings Aidoc's total funding to over $500 million, reflecting strong investor confidence in AI-driven healthcare solutions.
Founded to tackle inefficiencies in medical imaging, Aidoc develops AI systems that analyze CT scans and X-rays to help physicians detect critical conditions faster. Its platform is already deployed across nearly 2,000 hospitals and processes tens of millions of patient cases annually, assisting with triage and diagnosis in high-pressure clinical settings.
The new capital will be used to advance the company's clinical foundation model' CARE™, and expand its enterprise AI platform, which integrates directly into hospital workflows. Aidoc is also investing in new capabilities such as automated radiology reporting and broader disease coverage, aiming to reduce diagnostic delays and improve patient outcomes.
The funding comes amid rising demand for scalable AI tools in healthcare, where diagnostic errors and delays remain a major challenge. By offering system-wide solutions rather than single-use tools, Aidoc is positioning itself at the forefront of a shift toward integrated, enterprise-grade clinical AI.
With fresh funding and growing adoption, Aidoc is now eyeing further global expansion and a potential IPO in the coming years, underscoring the accelerating momentum of AI in healthcare.
